61 results
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
and the Company or any of its Subsidiaries or Parents, as applicable, an Award that vests, is earned or paid-out upon the satisfaction of one or more performance
S-3ASR
EX-4.2
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
by Merger, Etc
Section 7.10 Eligibility; Disqualification
Section 7.11 Preferential Collection of Claims Against Company
ARTICLE VIII SATISFACTION … AND DISCHARGE; DEFEASANCE
Section 8.1 Satisfaction and Discharge of Indenture
Section 8.2 Application of Trust Funds; Indemnification
Section 8.3 Legal
8-K
ORIC
ORIC Pharmaceuticals Inc
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
projected in any of such statements due to various factors, including risks and uncertainties associated with market conditions and the satisfaction
8-K
EX-10.1
umoen90d
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
8-K
EX-99.1
syfyq1prvyb
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
8-K
echhgwtv3zr
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-4.1
4cmixba
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-10.1
5fdrk
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.1
mttjr1qa062fokm
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.2
jsbecbldqo6tpw7jpc
21 Dec 22
Other Events
5:25pm
8-K
eo872wc65mcan
21 Dec 22
Other Events
5:25pm
424B5
soiiw5nso9 2scr
21 Dec 22
Prospectus supplement for primary offering
5:23pm